Cross-reactivity and T-cell receptor antagonism of myelin basic protein-reactive T cells is modulated by the activation state of the antigen presenting cell

Journal of Autoimmunity

Volumn 19, Issue 4, 2002, Pages 183-193

  Kissler, Stephan ^a,b   Anderton, Stephen M ^a,c   Wraith, David C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Autoimmunity; Co stimulation; Cross reactivity; TCR antagonism

Indexed keywords

MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CROSS REACTION; DENDRITIC CELL; IMMUNOMODULATION; IMMUNOREACTIVITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0037004919     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2002.0614     Document Type: Article

References (26)

1. Wraith D.C., Bruun B., Fairchild P.J. Cross-reactive antigen recognition by an encephalitogenic T cell receptor. Implications for T cell biology and autoimmunity. J. Immunol. 149:1992;3765-3770.
2. Bhardwaj V., Kumar V., Geysen H.M., Sercarz E.E. Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells: implications for autoimmunity. J. Immunol. 151:1993;5000-5010.
3. Reay P.A., Kantor P.M., Davis M.M. Use of global amino acid replacement to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 152:1994;3946-3957.
4. Wucherpfennig K.W., Strominger J.L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:1995;695-705.
5. Kaliyaperumal A., Mohan C., Wu W., Datta S.K. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J. Exp. Med. 183:1996;2459-2469.
6. Kersh G.J., Allen P.M. Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognise a large continuum of related ligands. J. Exp. Med. 184:1996;1259-1268.
7. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today. 19:1998;394-404.
8. Borghans J.A.M., Noest A.J., De Boer R.J. How specific should immunological memory be? J. Immunol. 163:1999;569-575.
9. Oldstone M.B.A., Schwimmbeck P., Dyrberg T., Fujinami R. Mimicry by virus of host molecules: implications for autoimmune disease. Prog. Immunol. 6:1986;787-793.
10. Liu G.Y., Fairchild P.J., Smith R.M., Prowle J.R., Kioussis D., Wraith D.C. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity. 3:1995;407-415.
11. Anderton S.M., Manickasingham S.P., Burkhart C., Luckcuck T.A., Holland S.J., Lamont A.G., Wraith D.C. Fine-specificity of the myelin reactive T cell repertoire: implications for TCR antagonism in autoimmunity. J. Immunol. 161:1998;3357-3364.
12. Anderton S.M., Kissler S., Lamont A.G., Wraith D.C. Therapeutic potential of T cell receptor antagonists is determined by their ability to modulate a diverse repertoire of autoreactive T cells. Eur. J. Immunol. 29:1999;1850-1857.
13. Wraith D.C., Smilek D.E., Mitchell D.J., Steinman L., McDevitt H.O. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell. 59:1989;247-255.
14. Stewart J., Glass E.J., Weir D.M., Daha M.R. Chapter title. Weir D.M., Herzenberg L.A., Blackwell C. Handbook of Experimental Immunology. 1985;48.1-48.17 Blackwell Scientific Publications, Oxford.
15. De Magistris M.T., Alexander J., Coggeshall M., Altman A., Gaeta F.C.A., Grey H.M., Sette A. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 68:1992;625-634.
16. Viola A., Linkert S., Lanzavecchia A. A T cell receptor antagonist competitively inhibits serial TCR triggering by low-affinity ligands, but does not affect triggering by high-affinity anti-CD3 antibodies. Eur. J. Immunol. 27:1997;3080-3083.
17. Bachmann M.F.D., Speiser D.E., Zakarian A., Ohashi P.S. Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism. Eur. J. Immunol. 28:1998;3110-3119.
18. Matsui K., Boniface J.J., Steffner P., Reay P.A., Davis M.M. Kinetics of T-cell receptor binding to peptide/I-E(k) complexes: correlation of the dissociation rate with T-cell responsiveness. Proc. Natl. Acad. Sci. USA. 91:1994;12862-12866.
19. McKeithan T.W. Kinetic proofreading in T cell receptor signal transduction. Proc. Natl. Acad. Sci. USA. 92:1995;5042-5046.
20. Rabinowitz J.D., Beeson C., Lyons D.S., Davis M.M., McConell H.M. Kinetic discrimination in T-cell activation. Proc. Natl. Acad. Sci. USA. 93:1996;1401-1405.
21. Bachmann M.F., Salzmann M., Oxnenius A., Ohashi P.S. Formation of TCR dimers/trimers as a crucial step for T cell activation. Eur. J. Immunol. 28:1998;2571-2579.
22. Cochran J.R., Cameron T.O., Stern L.J. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers. Immunity. 12:2000;241-250.
23. Valitutti S., Mueller S., Cella M., Padovan E., Lanzavecchia A. Serial triggering of many T cell receptors by a few peptide-MHC complexes. Nature. 375:1995;148-151.
24. Viola A., Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science. 273:1996;104-106.
25. Anderson D.E., Ausubel L.J., Krieger J., Hollsberg P., Gordon J.F., Hafler D.A. Weak peptide agonists reveal functional differences in B7-1 and B7-2 costimulation of human T cell clones. J. Immunol. 159:1997;1669-1675.
26. Murtaza A., Kuchroo V.K., Freeman G.J. Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands. Int. Immunol. 11:1998;407-416.